A generic biokinetic model for noble gases with application to radon

Parameter uncertainty analysis of the equivalent lung dose coefficient for the intake of radon in mines: A review

Radon presents significant health risks due to its short-lived progeny. The evaluation of the equivalent lung dose coefficient is crucial for assessing the potential health effects of radon exposure. This review focuses on the uncertainty analysis of the parameters associated with the calculation of the equivalent lung dose coefficient attributed to radon inhalation in mines. This analysis is complex due to various factors, such as geological conditions, ventilation rates, and occupational practices. The literature review systematically examines the sources of radon and its health effects among underground miners. It also discusses the human respiratory tract model used to calculate the equivalent lung dose coefficient and the associated parameters leading to uncertainties in the calculated lung dose. Additionally, the review covers the different methodologies employed for uncertainty quantification and their implications on dose assessment. The text discusses challenges and limitations in current research practices and provides recommendations for future studies. Accurate risk assessment and effective safety measures in mining environments require understanding and mitigating parameter uncertainties.

An age- and sex-specific biokinetic model for radon. JOURNAL OF RADIOLOGICAL PROTECTION : OFFICIAL JOURNAL OF THE SOCIETY FOR RADIOLOGICAL PROTECTION 2023;43:041502. [PMID: 37725955 DOI: 10.1088/1361-6498/acfb19] [Citation(s) in RCA: 0] [Impact Index Per Article: 0]

Publication 137 of the International Commission on Radiological Protection (ICRP) describes a biokinetic model for radon used to derive dose coefficients for occupational intake of radon isotopes. The model depicts transfer of inhaled or ingested radon to blood, exchange of radon between blood and tissues, and gradual loss of radon from the body based on physical laws governing transfer of a non-reactive and soluble gas between materials. This paper describes an age- and sex-specific variation of that model developed for use in an upcoming ICRP series of reports on environmental intake of radionuclides by members of the public titled 'Dose Coefficients for Intakes of Radionuclides by Members of the Public'. The proposed model modifies the model structure and transfer coefficients presented in Publication 137 to allow more realistic dosimetric treatment of bone marrow and breast and expands the model to address pre-adult ages, based on the physical principles used in the development of the model of Publication 137 together with anatomical and physiological changes occurring during human development.

Radon Solubility in Different Tissues after Short Term Exposure

Radon, a naturally occurring radioactive noble gas, contributes significantly to lung cancer when incorporated from our natural environment. However, despite having unknown underlying mechanisms, radon is also used for therapeutic purposes to treat inflammatory diseases such as rheumatoid arthritis. Data on the distribution and accumulation of radon in different tissues represent an important factor in dose determination for risk estimation, the explanation of potential therapeutic effects and the calculation of doses to different tissues using biokinetic dosimetry models. In this paper, radon's solubility in bones, muscle tissue, adipose tissue, bone marrow, blood, a dissolved gelatin and oleic acid were determined. In analogy to current radon use in therapies, samples were exposed to radon gas for 1 h using two exposure protocols combined with established γ-spectroscopic measurements. Solubility data varied over two orders of magnitude, with the lowest values from the dissolved gelatin and muscle tissue; radon's solubility in flat bones, blood and adipose tissue was one order of magnitude higher. The highest values for radon solubility were measured in bone marrow and oleic acid. The data for long bones as well as bone marrow varied significantly. The radon solubility in the blood suggested a radon distribution within the body that occurred via blood flow, reaching organs and tissues that were not in direct contact with radon gas during therapy. Tissues with similar compositions were expected to reveal similar radon solubilities; however, yellow bone marrow and adipose tissue showed differences in solubility even though their chemical composition is nearly the same-indicating that interactions on the microscopic scale between radon and the solvent might be important. We found high solubility in bone marrow-where sensitive hematopoietic cells are located-and in adipose tissue, where the biological impact needs to be further elucidated.

Radon Solubility and Diffusion in the Skin Surface Layer

In specific situations such as bathing in a radon spa, where the radon activity concentration in thermal water is far higher than that in air, it has been revealed that radon uptake via skin can occur and should be considered for more precise dose evaluation. The primary aim of the present study was to numerically demonstrate the distribution as well as the degree of diffusion of radon in the skin, with a focus on its surface layer (i.e., stratum corneum). We developed a biokinetic model that included diffusion theory at the stratum corneum, and measured radon solubility in that tissue layer as a crucial parameter. The implementation of the model suggested that the diffusion coefficient in the stratum corneum was as low as general radon-proof sheets. After a 20-min immersion in water, the simulated depth profile of radon in the skin showed that the radon activity concentration at the top surface skin layer was approximately 103 times higher than that at the viable skin layer. The information on the position of radon as a radiation source would contribute to special dose evaluation where specific target cell layers are assumed for the skin.

In-vivo dose determination in a human after radon exposure: proof of principle

Radon-222 is pervasive in our environment and the second leading cause of lung cancer induction after smoking while it is simultaneously used to mediate anti-inflammatory effects. During exposure, radon gas distributes inhomogeneously in the body, making a spatially resolved dose quantification necessary to link physical exposure conditions with accompanying risks and beneficial effects. Current dose predictions rely on biokinetic models based on scarce input data from animal experiments and indirect exhalation measurements of a limited number of humans, which shows the need for further experimental verification. We present direct measurements of radon decay in the abdomen and thorax after inhalation as proof of principle in one patient. At both sites, most of the incorporated radon is removed within ~ 3 h, whereas a smaller fraction is retained longer and accounts for most of the deposited energy. The obtained absorbed dose values were [Formula: see text] µGy (abdomen, radon gas) and [Formula: see text] µGy (thorax, radon and progeny) for a one-hour reference exposure at a radon activity concentration of 55 kBq m^-3. The accumulation of long-retained radon in the abdomen leads to higher dose values at that site than in the thorax. Contrasting prior work, our measurements are performed directly at specific body sites, i.e. thorax and abdomen, which allows for direct spatial distinction of radon kinetics in the body. They show more incorporated and retained radon than current approaches predict, suggesting higher doses. Although obtained only from one person, our data may thus represent a challenge for the barely experimentally benchmarked biokinetic dose assessment model.

Dosimetric Comparison of Exposure Pathways to Human Organs and Tissues in Radon Therapy

Three therapeutic applications are presently prescribed in the radon spas in Gastein, Austria: exposure to radon in a thermal bath, exposure to radon vapor in an exposure chamber (vapor bath), and exposure to radon in the thermal gallery, a former mine. The radiological exposure pathways to human organs and tissues in these therapeutic radon applications are inhalation of radon and radon progeny via the lungs, radon transfer from water or air through the skin, and radon-progeny deposition on the skin in water or air. The objectives of the present study were to calculate radon and radon-progeny doses for selected organs and tissues for the different exposure pathways and therapeutic applications. Doses incurred in red bone marrow, liver, kidneys, and Langerhans cells in the skin may be correlated with potential therapeutic benefits, while doses to the lungs and the basal cells of the skin indicate potential carcinogenic effects. The highest organ doses among the three therapeutic applications were produced in the thermal gallery by radon progeny via inhalation, with lung doses of 5.0 mSv, and attachment to the skin, with skin doses of 4.4 mSv, while the radon contribution was less significant. For comparison, the primary exposure pathways in the thermal bath are the radon uptake through the skin, with lung doses of 334 μSv, and the radon-progeny attachment to the skin, with skin doses of 216 μSv, while the inhalation route can safely be neglected.

Dosimetry of radon progeny deposited on skin in air and thermal water

It is held that the skin dose from radon progeny is not negligibly small and that introducing cancer is a possible consequence under normal circumstances as there are a number of uncertainties in terms of related parameters such as activity concentrations in air and water, target cells in skin, skin covering materials, and deposition velocities. An interesting proposal has emerged in that skin exposure to natural radon-rich thermal water as part of balneotherapy can produce an immune response to induce beneficial health effects. The goal of this study was to obtain generic dose coefficients with a focus on the radon progeny deposited on the skin in air or water in relation to risk or treatment assessments. We thus first estimated the skin deposition velocities of radon progeny in air and thermal water based on data from the latest human studies. Skin dosimetry was then performed under different assumptions regarding alpha-emitting source position and target cell (i.e. basal cells or Langerhans cells). Furthermore, the impact of the radon progeny deposition on effective doses from all exposure pathways relating to 'radon exposure' was assessed using various possible scenarios. It was found that in both exposure media, effective doses from radon progeny inhalation are one to four orders of magnitude higher than those from the other pathways. In addition, absorbed doses on the skin can be the highest among all pathways when the radon activity concentrations in water are two or more orders of magnitude higher than those in air.

Low Radon Cleanroom for Underground Laboratories

Aim of a low radon cleanroom technology is to minimize at the same time radon, radon decay products concentration and aerosol concentration and to minimize deposition of radon decay products on the surfaces. The technology placed in a deep underground laboratory such as LSM Modane with suppressed muon flux and shielded against external gamma radiation and neutrons provides "Zero dose" space for basic research in radiobiology (validity of the LNT hypothesis for very low doses) and for the fabrication of nanoelectronic circuits to avoid undesirable "single event effects." Two prototypes of a low radon cleanroom were built with the aim to achieve radon concentration lower than 100 mBq·m³ in an interior space where only radon-free air is delivered into the cleanroom technology from a radon trapping facility. The first prototype, built in the laboratory of SÚRO Prague, is equipped with a standard filter-ventilation system on the top of the cleanroom with improved leakproofness. In an experiment, radon concentration of some 50 mBq·m^-3 was achieved with the filter-ventilation system switched out. However, it was not possible to seal the system of pipes and fans against negative-pressure air leakage into the cleanroom during a high volume ventilation with the rate of 3,500 m³·h^-1. From that reason more sophisticated second prototype of the cleanroom designed in the LSM Modane uses the filter-ventilation system which is completely covered in a further improved leakproof sealed metal box placed on the top of the cleanroom. Preliminary experiments carried out in the SÚRO cleanroom with a high radon activity injection and intensive filter-ventilation (corresponding to room filtration rate every 13 s) showed extremely low radon decay products equilibrium factor of 0.002, the majority of activity being in the form of an "unattached fraction" (nanoparticles) of ²¹⁸Po and a surface deposition rate of some 0.05 mBq·m^-2·s^-1 per Bq·m^-3. Radon exhalation from persons may affect the radon concentration in a low radon interior space. Balance and time course of the radon exhalation from the human body is therefore discussed for persons that are about to enter the cleanroom.

Radon Exposure-Therapeutic Effect and Cancer Risk

Largely unnoticed, all life on earth is constantly exposed to low levels of ionizing radiation. Radon, an imperceptible natural occurring radioactive noble gas, contributes as the largest single fraction to radiation exposure from natural sources. For that reason, radon represents a major issue for radiation protection. Nevertheless, radon is also applied for the therapy of inflammatory and degenerative diseases in galleries and spas to many thousand patients a year. In either case, chronic environmental exposure or therapy, the effect of radon on the organism exposed is still under investigation at all levels of interaction. This includes the physical stage of diffusion and energy deposition by radioactive decay of radon and its progeny and the biological stage of initiating and propagating a physiologic response or inducing cancer after chronic exposure. The purpose of this manuscript is to comprehensively review the current knowledge of radon and its progeny on physical background, associated cancer risk and potential therapeutic effects.

RADON INHALATION EXPERIMENTS TO TEST RADON EXHALATION KINETICS

Three experiments were conducted with a volunteer to test the kinetics of the 222Rn exhalation after a short-time exposure to an elevated 222Rn air concentration. Radon concentration in an exhaled air was measured, complemented by whole body counting of 222Rn decay products in a body. Exhaled activities are compared with the prediction of the recent ICRP biokinetic model for radon. While a rapid equilibration of the exhaled radon activity concentration with that in the air inhaled corresponded with the model, the measured 222Rn exhalation rate was significantly less than modelled. Five hours after termination of the inhalation phase, the radon concentration in the exhaled air decreased to levels expected for non-elevated indoor radon activity concentration. Whole body activities of the 222Rn decay products were found higher than expected. Inhalation of the unattached fraction or residual activity of decay products in the air inhaled may be the explanation.

A DISCUSSION ON ISSUES WITH RADON IN DRINKING WATER

The majority of the world's population relies on surface water or large public supply systems of groundwater, where radon is low and a guidance value for radon in drinking water is not necessary. However, the International Commission on Radiological Protection (ICRP) recently issued a dose coefficient for radon ingestion, raising questions among some radiation protection authorities about whether radon guidance values should be calculated for drinking water and how this might be done. Unlike many other radionuclides considered in drinking water management, radon has special characteristics and therefore requires special considerations. This note discusses some of these considerations, and also provides a brief review of radon concentrations measured in well-water supplies, especially private well-water systems, and cold tap water consumption rates reported in different countries.

VARIATION SIMULATION OF RADON CONCENTRATION IN THE TISSUES AND ORGANS OF THE BODY BY AN ELECTRICAL CIRCUIT

In this study, a new model based on electric circuit theory has been introduced to simulate the dynamics of radioactive chemically inert gases in the human body. For this manner, it is assumed that inert gas is transported through the body to various organs via the blood stream. In this simulation, a voltage source is equivalent to gas generation in the atmosphere, the conductivity is equivalent to the cardiac output of the organ, the capacitor capacitance is equivalent to the volume of blood or tissue and voltage across a capacitor is equivalent to the gas concentration in air or blood or a tissue. This simulation can be used to study the dynamics of any inert gas whose partition coefficients are known. We use this simulation to study the dynamics of radon in human body. The physiologically based pharmacokinetic (PBPK) model that describes the fate of radon in systemic tissue has been used for this simulation. Using this simulation, the effective dose equivalent resulting from inhalation of radon has been estimated. The calculated values agree with the previously reported value. Also, using the model, it has been shown that after inhalation of radon gas, absorbed dose has been decreased in different tissues by increasing the inhalation rate without radon. So that, by doubling the inhalation rate and the rate of cardiac output, the value of the absorbed dose has been decreased 11.88% in the adipose tissue, 25.49% in the red marrow tissue and 20.3% in the liver organ.

Radon transfer from thermal water to human organs in radon therapy: exhalation measurements and model simulations

The transfer of radon from thermal water via the skin to different human organs in radon therapy can experimentally be determined by measuring the radon activity concentration in the exhaled air. In this study, six volunteers were exposed to radon-rich thermal water in a bathtub, comprising eleven measurements. Exhaled activity concentrations were measured intermittently during the 20 min bathing and 20 min resting phases. Upon entering the bathtub, the radon activity concentration in the exhaled breath increased almost linearly with time, reaching its maximum value at the end of the exposure, and then decreased exponentially with time in the subsequent resting phase. Although for all individuals the time-dependence of exhaled radon activity was similar during bathing and resting, significant inter-subject variations could be observed, which may be attributed to individual respiratory parameters and body characteristics. The simulation of the transport of radon through the skin, its distribution among the organs, and the subsequent exhalation via the lungs were based on the biokinetic model of Leggett and co-workers, extended by a skin and a subcutaneous fat compartment. The coupled linear differential equations describing the radon activity concentrations in different organs as a function of time were solved numerically with the program package Mathcad. An agreement between model simulations and experimental results could only be achieved by expressing the skin permeability coefficient and the arterial blood flow rates as a function of the water temperature and the swelling of the skin.

Measurements of radon activity concentration in mouse tissues and organs

The purpose of this study is to investigate the biokinetics of inhaled radon, radon activity concentrations in mouse tissues and organs were determined after mice had been exposed to about 1 MBq/m³ of radon in air. Radon activity concentrations in mouse blood and in other tissues and organs were measured with a liquid scintillation counter and with a well-type HP Ge detector, respectively. Radon activity concentration in mouse blood was 0.410 ± 0.016 Bq/g when saturated with 1 MBq/m³ of radon activity concentration in air. In addition, average partition coefficients obtained were 0.74 ± 0.19 for liver, 0.46 ± 0.13 for muscle, 9.09 ± 0.49 for adipose tissue, and 0.22 ± 0.04 for other organs. With these results, a value of 0.414 for the blood-to-air partition coefficient was calculated by means of our physiologically based pharmacokinetic model. The time variation of radon activity concentration in mouse blood during exposure to radon was also calculated. All results are compared in detail with those found in the literature.

Direct total body 214Bi measurements and their implications for radon dose assessment

Direct ²¹⁴Bi bioassays may elucidate some of the uncertainties related to the relationship between the ambient concentration of radon and its short-lived decay products and the corresponding radiation burdens of individual human subjects. Sequential total body ²¹⁴Bi activity measurements were carried out on a group of 67 healthy adult volunteers living in a region with moderate airborne radioactivity and conducting similar daily activities using a whole-body counter equipped with sixteen NaI(Tl) detectors. The total body ²¹⁴Bi activity in the studied subjects was related to gender, fat-free mass and the season of the year. Approximately 95% and 92% of the ²¹⁴Bi activity measured during the cold seasons of the year in men and women, respectively, was attributed to radon progeny inhalation. Following acute exposure to high airborne radioactivity over a short time period, the ²¹⁴Bi enhancement in a volunteer decreased exponentially with time post-exposure, with a half-time of about 40 min. Taking into account the anticipated low ²¹⁴Bi activity in the vast majority of individuals, and the uncertainties in ²¹⁴Bi biodistribution even during counting, accurate measurements can be obtained using high-sensitivity whole-body counters with almost geometrical invariant counting efficiency.

Evaluation of the intake of radon through skin from thermal water

The biokinetics of radon in the body has previously been studied with the assumption that its absorption through the skin is negligibly small. This assumption would be acceptable except in specific situations, such as bathing in a radon hot spring where the radon concentration in thermal water is far higher than that in air. The present study focused on such a situation in order to better understand the biokinetics of radon. To mathematically express the entry of radon through the skin into the body, we first modified the latest sophisticated biokinetic model for noble gases. Values of an important parameter for the model-the skin permeability coefficient K (m s(-1))-were derived using data from previous human studies. The analysis of such empirical data, which corresponded to radon concentrations in the air exhaled by subjects during and following bathing in radon-rich thermal water, revealed that the estimated K values had a log-normal distribution. The validity of the K values and the characteristics of the present model are then discussed. Furthermore, the impact of the intake of radon or its progeny via inhalation or skin absorption on radiation dose was also assessed for possible exposure scenarios in a radon hot spring. It was concluded that, depending on the radon concentration in thermal water, there might be situations in which the dose contribution resulting from skin absorption of radon is comparable to that resulting from inhalation of radon and its progeny. This conclusion can also apply to other therapeutic situations (e.g. staying in the pool for a longer period).